Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ramstad/Thurman, AdvaMed Urge CMS To Begin Restructuring APCs

This article was originally published in The Gray Sheet

Executive Summary

The Centers for Medicare and Medicaid Service (CMS, formerly HCFA) should begin restructuring the ambulatory payment classification (APC) system to capture medical device costs, Reps. Jim Ramstad (R-Minn.) and Karen Thurman (D-Fla.) assert in a letter to HHS Secretary Tommy Thompson and CMS Administrator Tom Scully

You may also be interested in...



Hospitals To Evaluate Industry's OPPS Fix, May Develop Alternative Proposal

Hospitals are asking CMS to provide financial and utilization data on the outpatient prospective payment system (OPPS) so they can explore the feasibility of a device industry proposal to transfer new technology "pass-through" payments into ambulatory payment classification groups.

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015055

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel